Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies2,921–2,940 of 20,710
All studies
Exploring the mental health challenges faced by females with polycystic ovary syndrome (PCOS)
Is the risk of ovarian hyperstimulation syndrome adequately addressed in high anti-Müllerian hormone and PCOS patients undergoing IVF?
What is the long-term prognosis for patients diagnosed with polycystic ovary syndrome (PCOS)?
Management of adolescent polycystic ovary syndrome
Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
MON-148 Comparative Metabolic Effects Of High, Moderate, And Low-intensity Exercise In Polycystic Ovary Syndrome: A Systematic Review And Network Meta-analysis Of Randomized Controlled Trials
Investigating the Relationship Between Serum Anti-Müllerian Hormone Levels and In Vitro Fertilization Outcomes in Women with Polycystic Ovary Syndrome
Polycystic ovary syndrome prevalence and nutrient intake: A cross-sectional study in Jamshedpur
The Effect of Naproxen on Oxidative Stress Markers, Malondialdehyde and Superoxide Dismutase in Wistar Rat Model of Polycystic Ovary Syndrome
"COMPARATIVE EVALUATION OF ABRUS PRECATORIUS (GUNJA) IN THE MANAGEMENT OF OBESITY-RELATED POLYCYSTIC OVARY SYNDROME(PCOS)"
Targeting the Renin Angiotensin System Ameliorates Cognitive Dysfunction in Polycystic Ovary Syndrome
Management of Polycystic Ovary Syndrome through Virechana Therapy: A Case Report
Diagnostic Delay in Acromegaly Due to Overlapping Features With Polycystic Ovary Syndrome: A Case Report
A Comparative Study of Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Models in Immature and Prepubertal Female Rats
Evaluation of Reproductive Hormones (FSH, LH, E2, and Prolactin) in Patients From Bosnia With Polycystic Ovary Syndrome
Association of APOE Gene Variants with Cognitive Dysfunction in Polycystic Ovary Syndrome
Mentha spicata and Its Bioactive Compound Carvone Ameliorate Metabolic Disturbance and Ovarian Dysfunction in Experimental Rat Model of PCOS by Suppression of SREBP1/TLR4-Dependent Pathway.
ESTIMATE OF THE CARRIER FREQUENCY OF GENETIC VARIANTS ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME IN THE RUSSIAN POPULATION (BASED ON GWAS AND RUSeq DATA)
Reduced miR-338-3p contributes to polycystic ovarian syndrome by inhibiting proliferation and enhancing apoptosis.
Risk factors of Non Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome